SmartCella Holding AB

SmartCella Holding AB is a Swedish biotechnology company specializing in targeted therapies. Their mission is to pioneer new treatment paradigms and transform lives for patients in need. They achieve this by combining innovative delivery platforms with cutting-edge cell and gene therapies. Their three main business units are: SmartWise, which develops and manufactures the FDA-approved Extroducer, an endovascular delivery device enabling direct tissue/organ infusions; ProCella, which specializes in stem cell therapy development and inhouse cGMP manufacturing; and SmartCella Solutions, which creates novel mRNA therapies and platforms for cell-mediated delivery.

SmartCella is privately owned and funded, headquartered in Stockholm, Sweden, and employs approximately 60 individuals. The company has a strong focus on research and development, and is committed to establishing a world-leading biotech cluster in Stockholm. They have secured several collaborations, including one with AstraZeneca for the development of a cardiac stem cell therapy. SmartCella's vision is to unleash the full potential of targeted therapies by bringing together leading-edge technologies and a highly skilled and diverse team.

SmartCella is a Swedish biotechnology company focused on pioneering targeted therapies by combining innovative delivery platforms with cutting-edge cell and gene therapies. Their mission is to develop treatments for patients who have run out of options by addressing significant unmet needs in the fields of cardiovascular disease, cancer, and other chronic conditions. Their three main business units, SmartWise, SmartCella Solutions, and ProCella, collaborate to deliver therapies directly to hard-to-reach organs and tumors using their FDA-approved Extroducer device, develop novel mRNA therapies and platforms for cell-mediated delivery, and advance stem cell therapy development and cGMP manufacturing, respectively.

SmartCella fosters a collaborative and innovative culture that values scientific excellence, entrepreneurial spirit, and a shared commitment to improving patient lives. The company attracts a diverse workforce of over 20 nationalities, bringing together talented scientists and researchers from various backgrounds. They encourage open communication, cross-functional teamwork, and a willingness to embrace new ideas, creating an environment where employees feel empowered to contribute to the company's mission of pioneering targeted therapies.

SmartCella values diversity, equity and inclusion as a key component of their success. They foster a culture of collaboration and innovation by actively recruiting and retaining employees from diverse backgrounds, promoting equal opportunities for advancement, and creating an inclusive work environment where everyone feels valued and respected. They believe that a diverse team brings a wider range of perspectives, expertise, and experiences that contribute to their research, development, and business operations.